Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:35:58.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study location entry was updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-05T06:19:24.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as the condition, included the Genetic and Rare Diseases Information Center as a resource, and updated the location entry from Napoli to Naples, Campania, Italy (80131) with revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:51:58.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No study content or usability aspects appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-07T05:26:43.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Removed the sponsor link 'Click here to find results for studies related to Bayer Healthcare products' from the Bayer Helpful Links section. This change does not affect the core study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-02-20T20:26:55.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Minor site revision updated from v3.4.1 to v3.4.2 with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:24:23.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.